NCT05152615View on ClinicalTrials.gov

A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions

Rheumatoid Arthritis

Interventions

DIETARY_SUPPLEMENT

Short Chain Fatty Acids (SCFA) Dietary Supplement

Butryate 1000 mg three times daily will be used in this study.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT05152615 - A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA) | Biotech Hunter | Biotech Hunter